Brief: CytoMed Therapeutics Sees U.S. IPO Of Up To 2.4 Mln Shares - SEC Filing
Feb 1 (Reuters) - Cytomed Therapeutics Pte Ltd GDTC.O :
* CYTOMED THERAPEUTICS PTE LTD NOW SEES U.S. IPO OF UP TO
2.4
MILLION ORDINARY SHARES - SEC FILING
* CYTOMED THERAPEUTICS PTE LTD SAYS OFFERING PRICE OF
ORDINARY
SHARES IN OFFERING IS EXPECTED TO BE BETWEEN U.S.$4.00 AND
U.S.$5.00 PER SHARE
Source: (shorturl.at/gnQTV)
Further company coverage: GDTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytoMed Therapeutics
See all newsBrief: Cytomed Therapeutics Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: CytoMed Therapeutics To Start Dose Level 2 In Angelica Trial Q3 2025
Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million